Beam Therapeutics Inc. Liabilities (Preferred Stock)

Liabilities (Preferred Stock) of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Liabilities (Preferred Stock) growth rates and interactive chart.


Highlights and Quick Summary

  • Liabilities (Preferred Stock) for the quarter ending December 31, 2019 was $302 Million
  • Annual Liabilities (Preferred Stock) for 2019 was $302 Million (a 20.13% increase from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Liabilities (Preferred Stock) of Beam Therapeutics Inc.

Most recent Liabilities (Preferred Stock)of BEAM including historical data for past 10 years.

Interactive Chart of Liabilities (Preferred Stock) of Beam Therapeutics Inc.

Beam Therapeutics Inc. Liabilities (Preferred Stock) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 $302.05 $302.05
2018 $251.43

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology